 | | PRD_002316 | | Name: | Apollo peptide | | Formula: | C46 H68 N8 O7 | | Definition date: | 2019-02-13 | | Last modified: | 2019-02-13 |
|
 | | PRD_002284 | | Formula: | C37 H57 N11 O11 | | Definition date: | 2018-11-07 | | Last modified: | 2018-11-07 |
|
 | | PRD_002328 | | Name: | TYROSTATIN (Bound Form) | | Formula: | C29 H41 N3 O6 | | Definition date: | 2018-10-24 | | Last modified: | 2018-10-31 |
|
 | | PRD_002327 | | Name: | PSEUDOTYROSTATIN (Bound Form) | | Formula: | C23 H30 N2 O5 | | Definition date: | 2018-10-24 | | Last modified: | 2018-10-24 |
|
 | | PRD_002331 | | Name: | Chymostatin A (bound form) | | Formula: | C31 H43 N7 O6 | | Definition date: | 2018-10-24 | | Last modified: | 2018-10-24 |
|
 | | PRD_002298 | | Name: | N2-[4-(carbamimidamidomethyl)phenyl]acetyl-D-lysyl-L-lysyl-D-arginine | | Formula: | C28 H51 N11 O5 | | Definition date: | 2018-10-17 | | Last modified: | 2018-10-17 |
|
 | | PRD_002304 | | Name: | N2-{[4-(carbamimidamidomethyl)phenyl]acetyl}-L-arginyl-L-arginyl-N-[(4-carbamimidoylphenyl)methyl]-L-argininamide | | Formula: | C36 H61 N18 O4 | | Definition date: | 2018-10-17 | | Last modified: | 2018-10-17 |
|
 | | PRD_002309 | | Name: | N2-(phenylacetyl)-D-lysyl-D-lysyl-D-arginine | | Formula: | C26 H45 N8 O5 | | Definition date: | 2018-10-17 | | Last modified: | 2018-10-17 |
|
 | | PRD_002317 | | Name: | N-Me-p-iodo-D-Phe1,N-Me-D-Gln4,Lys10-teixobactin analogue | | Formula: | C59 H99 I N13 O15 | | Definition date: | 2018-10-17 | | Last modified: | 2018-10-17 |
|
 | | PRD_002307 | | Name: | Phalloidin | | Formula: | C35 H48 N8 O11 S | | Definition date: | 2018-09-19 | | Last modified: | 2018-09-19 |
|
 | | PRD_002323 | | Name: | N-METHYL-4-HYDROXY-LEUCINE CYCLOSPORIN | | Formula: | C62 H111 N11 O13 | | Definition date: | 2018-09-12 | | Last modified: | 2018-09-12 |
|
 | | PRD_002324 | | Name: | [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN | | Formula: | C62 H111 N11 O13 | | Definition date: | 2018-09-12 | | Last modified: | 2018-09-12 |
|
 | | PRD_002318 | | Name: | SRC2-BCP1 | | Formula: | C64 H109 N19 O15 | | Definition date: | 2018-07-25 | | Last modified: | 2018-07-25 |
|
 | | PRD_002227 | | Name: | (2R)-N-[2-[[(2S)-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-2-oxidanylidene-ethyl]-5-oxidanylidene-1,2-dihydropyrrole-2-carboxamide | | Formula: | C13 H20 N6 O4 | | Definition date: | 2018-07-11 | | Last modified: | 2018-07-11 |
|
 | | PRD_002229 | | Name: | (2R)-N-[2-[[(2S)-1-[[4-[bis(oxidanyl)amino]phenyl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-2-oxidanylidene-ethyl]-5-oxidanylidene-pyrrolidine-2-carboxamide | | Formula: | C19 H28 N8 O6 | | Definition date: | 2018-07-11 | | Last modified: | 2018-07-11 |
|
 | | PRD_002279 | | Name: | N-acetyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl-N-[(1R,4S,7S,10S,19S,22S,25S,28R)-28-{[(2R)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl}-25-(3-amino-3-oxopropyl)-4-[(1H-imidazol-3-ium-4-yl)methyl]-10,19-dimethyl-7,22-bis(2-methylpropyl)-3,6,9,20,23,26,30,36-octaoxo-2,5,8,21,24,27,31,37-octaazabicyclo[17.16.2]heptatriacontan-31-ium-10-yl]-6-azaniumyl-L-norleucinamide | | Formula: | C64 H109 N19 O15 | | Definition date: | 2018-06-13 | | Last modified: | 2018-06-13 |
|
 | | PRD_002302 | | Name: | benzyl [(6S,7S,10S,13S,18Z)-18-amino-10-cyclohexyl-6-hydroxy-18-imino-7-(2-methylpropyl)-4,9,12-trioxo-1-phenyl-16-oxa-3,8,11,17-tetraazaoctadecan-13-yl]carbamate | | Formula: | C37 H55 N7 O7 | | Definition date: | 2018-06-13 | | Last modified: | 2018-06-13 |
|
 | | PRD_002308 | | Name: | DAMGO | | Formula: | C26 H35 N5 O6 | | Definition date: | 2018-06-13 | | Last modified: | 2018-06-13 |
|
 | | PRD_002303 | | Name: | [(3-{(3S,6S,9S,15R,20aS)-15-[(N-acetyl-L-phenylalanyl)amino]-3-(cyclohexylmethyl)-6-[(1H-indol-3-yl)methyl]-1,4,7,10,16-pentaoxoicosahydropyrrolo[1,2-a][1,4,7,10,13]pentaazacyclooctadecin-9-yl}propyl)amino](amino)methaniminium | | Formula: | C47 H66 N11 O7 | | Definition date: | 2018-05-30 | | Last modified: | 2018-05-30 |
|
 | | PRD_002301 | | Formula: | C35 H47 N8 O11 S | | Definition date: | 2018-01-31 | | Last modified: | 2018-01-31 |
|
 | | PRD_001186 | | Name: | Myosin-A, stapled peptide | | Formula: | C97 H175 N31 O23 S | | Description: | SYNTHESISED PEPTIDE MIMIC OF PLASMODIUM FALCIPARUM MYOSIN A TAIL | | Definition date: | 2013-11-06 | | Last modified: | 2017-12-15 |
|
 | | PRD_002230 | | Name: | L-alpha-aspartyl-6-azaniumyl-L-norleucyl-O-phosphono-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-valyl-N-{(3R)-6-{[amino(iminio)methyl]amino}-1-[2-(methoxycarbonyl)-3,5-dimethylphenyl]-2-oxohexan-3-yl}glycinamide | | Formula: | C48 H81 N12 O18 P | | Definition date: | 2016-05-04 | | Last modified: | 2017-12-15 |
|
 | | PRD_002275 | | Formula: | C35 H59 N14 O13 | | Definition date: | 2017-06-14 | | Last modified: | 2017-12-15 |
|
 | | PRD_002277 | | Name: | N-{(2S,4R)-2-[(1R)-3-amino-1-({N-[(2R)-2-{(1R)-1-[(N-{(2S)-2-[(1S)-3-amino-1-({N-[(3S,6R)-3-(3-amino-3-oxopropyl)-6-(hydroxymethyl)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl]-L-seryl-L-prolylglycyl}amino)-3-oxopropyl]-2,3-dihydro-1,3-thiazole-4-carbonyl}-L-alanyl)amino]-2-hydroxyethyl}-2,3-dihydro-1,3-thiazole-4-carbonyl]-L-seryl}amino)-3-oxopropyl]-1,3-oxazolidine-4-carbonyl}-L-alanyl-L-seryl-N-{(1S)-3-amino-1-[(2S)-4-{[(2S,3S)-3-hydroxy-1-oxobutan-2-yl]carbamoyl}-2,3-dihydro-1,3-thiazol-2-yl]-3-oxopropyl}-L-alaninamide | | Formula: | C64 H93 N23 O25 S3 | | Definition date: | 2017-08-30 | | Last modified: | 2017-12-15 |
|
 | | PRD_002263 | | Name: | N-[(1S)-1-cyclohexyl-2-{[3-(morpholin-4-yl)propanoyl]amino}ethyl]-N~2~-propanoyl-3-[6-(propan-2-yl)-1,3-benzothiazol-2-yl]-L-alaninamide | | Formula: | C31 H47 N5 O4 S | | Definition date: | 2017-11-01 | | Last modified: | 2017-11-01 |
|
